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Actinomycosis is an uncommon, chronic, granulomatous disease caused by several species of the genus 
Actinomyces, a Gram-positive, filamentous bacterium that normally colonizes mucosal areas. Actinomycosis 
can be mistaken for malignant tumors, and in most cases the diagnosis is delayed or missed entirely until 
surgery. Actinomycosis in the abdomen or pelvis mostly results from prolonged use of an intrauterine device. 
We report the case of a 40-year-old female who presented with decreased urine production, poor appetite, 
marked loss of body weight and intermittent lower abdominal pain for 3 months. Abdominal computed 
tomography indicated a large infiltrative pelvic mass that was complicated by bilateral hydronephrosis, 
bladder compression and small bowel adhesions. Despite the elevated levels of cancer antigen 125, we sus-
pected pelvic actinomycosis because of a 15-year history of an intrauterine device. The diagnosis was con-
firmed by histopathological examination of soft tissue obtained from a laparotomy biopsy. We successfully 
treated the patient with prolonged antibiotics instead of surgical eradication. Abdominal computed tomog-
raphy obtained 1 year later showed almost complete resolution of the pelvic inflammatory mass. 
KEYWORDS: huge pelvic actinomycosis, hydronephrosis, intrauterine device, prolonged antibiotics
Introduction
Actinomycosis is an uncommon, chronic, granulomatous 
disease caused by several species of the genus Actinomyces, 
a Gram-positive, filamentous bacterium. Infection usu-
ally occurs after disruption of the mucous membranes 
and these organisms have been isolated from the mouth, 
bronchi, gastrointestinal tract and female genital tract.1 
In the female genital tract, intrauterine devices (IUD) can 
traumatize the endometrium, causing erosions that create 
a favorable environment for Actinomyces.1–3
When a woman presents with a pelvic tumor accompa-
nied by increased levels of cancer antigen 125 (CA-125), 
lower abdominal pain and loss of body weight, malignancy 
is typically the initial diagnosis. We describe a female 
patient with an IUD who presented with lower abdominal 
and pelvic actinomycosis, complicated by bilateral 
hydronephrosis, that was diagnosed during a scheduled 
diagnostic laparotomy and biopsy. The huge pelvic mass 
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almost completely resolved after a long period of antibiotic 
treatment instead of major surgical eradication. This case 
emphasizes the need to consider pelvic actinomycosis in a 
female patient with a history of prolonged IUD implanta-
tion, presenting as an infiltrated soft tissue mass arising 
from the tubo-ovarian region. The patient showed a good 
response to prolonged treatment with antibiotics, even 
with such a huge complicated pelvic actinomycosis. 
Case Report
A 40-year-old woman (gravida 2, para 2) was admitted 
with a 6-month history of lower abdominal pain, inter-
mittent fever and decreased urine production. Her lower 
abdominal pain was intermittent, localized below the um-
bilicus, and accompanied by elevated body temperature 
(above 38°C), poor appetite, marked loss of body weight 
(about 7 kg over the preceding 3 months), general malaise, 
decreased urine production and changeable bowel habits. 
On examination, her body temperature was 38.6°C, 
pulse rate was 98 beats/min, and blood pressure was 
130/80 mmHg. Physical examination showed pale con-
junctiva, hypoactive bowel sounds, non-pitting edema of 
the lower left leg, knocking pain in the bilateral flank and 
tenderness over the left side below the umbilicus. 
Laboratory tests indicated a white blood cell (WBC) 
count of 15.0 × 109/L with 82.7% neutrophils, a hemo-
globin level of 5.6 g/dL, and a platelet count of 
448.0 × 109/L. The C-reactive protein (CRP) level was 
16.0 mg/dL and the erythrocyte sedimentation rate (ESR) 
was 110 mm/hr. Urine examination indicated pyuria and 
a urine culture yielded Escherichia coli 3 days later. The liver 
function test was normal, but impaired renal function 
(creatinine = 2.2 mg/dL) was noted.
Pelvic ultrasound indicated a large pelvic mass with a 
blurred and irregular margin. Computed tomography 
(CT) of the abdomen showed an IUD in the endometrial 
cavity, a distended bladder, and a well-enhanced, infiltrat-
ing soft tissue mass (9.6 × 7.2 × 7.6 cm) over the lower ab-
domen and pelvis. The mass was adhered to the uterus 
and regional bowel loops and encased the bilateral lower 
ureter, causing bilateral hydroureter and hydronephro-
sis (Figure 1). Several tumor markers were tested, and 
increased levels of CA125 (97.17 U/mL; normal range, 
< 35.0 U/mL), but normal levels of alpha-feto protein, 
carcinoembryonic antigen and CA15-3 were found. Bilateral 
percutaneous nephrostomy was performed for obstruc-
tion relief.
Further gynecological inquiries revealed that the 
patient had been using an IUD for 15 years and had re-
cently experienced prolonged menstruation (about 14 
days) and increased vaginal discharge. A Pap smear was 
negative for malignancy and a cervical culture yielded 
E. coli. The IUD was removed and cultured. It was positive 
for Bacteroides fragilis and E. coli. We performed an open 
biopsy and found a firm and irregular mass (about 
7 × 6 cm) with adhesions to the intestine during laparot-
omy. After staining with Periodic acid-Schiff, acid-fast, 
Gram stains, and Gomori methenamine silver, pathologic 
sections revealed sulfur granules (hematoxylin and eosin 
stains) that were compatible with a diagnosis of actino-
mycosis (Figure 2). 
After confirmation of actinomycosis, we administered 
intra venous penicillin G (3 million U; q6 h) and clin-
damycin (300 mg, q6 h). Defervescence occurred 8 days 
later. Her renal function and clinical condition also 
improved. She was discharged after an 8-week course of 
penicillin via intravenous injection. She was prescribed 
oral penicillin V (400,000 U, q6 h) for 7 months, followed 
by amoxicillin (500 mg, q8 h) for the next 6 months. 
CT scans of the abdomen, performed 3 months, 9 months 
and 2 years after diagnosis, showed almost complete reso-
lution of the pelvic inflammatory mass (Figure 3). 
Discussion
Actinomycosis is a slowly progressive infection, most 
commonly caused by the anaerobic Gram-positive fila-
mentous bacteria, Actinomyces israeli. The most common 
forms of actinomycosis are cervicofacial, thoracic and ab-
dominogenital.4 Symptoms of abdominal and pelvic ac-
tinomycosis are typically indolent and nonspecific. The 
most common clinical presentations are fever (60%), ab-
dominal pain (85%) and body weight loss (44%).5 Typical 
findings from laboratory tests include: increased WBC 
count, anemia, increased CRP, ESR, CA-125 and CA-199.6 
When complicated by severe hydronephrosis, renal function 
deteriorates, presenting as increased blood urea nitrogen 
and creatine levels.7 Because the clinical mani festations of 
actinomycosis are many and the diagnosis is commonly 
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confused with a neoplasm, clinicians need to be more 
aware of this disease in order to minimize unnecessary sur-
gical interventions, morbidity and mortality.
Actinomyces-induced pelvic inflammation most com-
monly occurs via the ascending route from the uterus in as-
sociation with IUD.1,2,5,8–10 Mali B Actinomyces israeli is 
isolated from 10% of asymptomatic IUD users and 25% of 
symptomatic IUD users during routine vaginal examina-
tion.3 Lee and Hawnaur reviewed the incidence of actinomy-
cosis in IUD users and found that it was between 8–16% in 
most reports, and rises slightly after 2 years of IUD use.11,12 
Because this patient had most of the aforementioned ab-
normalities and a 15-year history of IUD implantation, she 
was at high risk of suffering from pelvic actinomycosis.
Imaging of abdominal and pelvic actinomycosis typi-
cally does not help with diagnosis because the disease usu-
ally presents as an abscess or a mass lesion and is mistaken 
for a tumor. Diagnosis is usually made after surgery, con-
firmed by pathologic examination and identification of 
sulfur granules in the pus or soft tissue mass.13 Before 
confirmation of the diagnosis, there should be differen-
tial diagnoses of abdominal tuberculosis, ovarian cancer, 
rectal cancer and other malignancies.14 Therefore, the 
most difficult factor with this uncommon disease is to 
make a correct diagnosis before a major operation is per-
formed. CT- or ultrasound-guided aspiration or needle 
biopsy may be useful to obtain a correct diagnosis.12,13 We 
performed an open biopsy on this patient because the 
lower abdominal mass was adhered to the uterus and 
regional bowel loops, increasing the risk associated with 
CT-guided biopsy. 
After pelvic actinomycosis is confirmed, administra-
tion of penicillin, as well as IUD removal, is the rule.15,16 
High-dose penicillin, administered over a prolonged 
period, is the cornerstone of therapy for actinomycosis. 
Current recommendations include an initial course of 
penicillin G at 20 million IU/day for 4 weeks, followed by 
oral penicillin V at a dose of 2–4 g/day for 12 months.16 
Surgery should be considered if malignancy cannot be 
definitely excluded, or if removal of persistent sinuses, 
abscess drainage, or excision of necrotic tissue is neces-
sary.12,16 Although there was a huge pelvic mass, close to 
9 cm in diameter and complicated with bilateral hydrone-
phrosis, in our patient, we explored the opportunity to 
avoid unnecessary surgical operation. Prolonged intrave-
nous penicillin for 8 weeks was prescribed due to the more 
severe pelvic infection in this patient. Oral penicillin V for 
7 months and amoxicillin for another 6 months were then 
prescribed until the soft tissue mass was completed re-
solved. The patient responded very well to conservative 
therapy. We also suggest that CT scans could be used to 
monitor the response to therapy and inform clinicians as 
to the required duration of treatment.
In summary, early and accurate diagnosis of actinomy-
cosis is challenging because it is an indolent, slowly-
progressive infection, and the clinical presentations are 
many and commonly confused with a neoplasia. Some 
clues may be helpful for early recognition of this disease, 
including the prolonged use of an IUD. Laboratory test 
results showing elevated WBC counts, anemia, increased 
ESR, CRP and CA-125 are common findings in actinomy-
cosis. If the abdominal CT scan shows a unilateral or bi-
lateral tubo-ovarian abscess, or mass, accompanied by 
renal/urinary tract distention, hydronephrosis or topical 
intestinal obstruction, a differential diagnosis of actino-
mycosis should be considered. Once diagnosis is established, 
A CB
Figure 1. Computed tomography of the abdomen on admission. (A) An intrauterine device in the endometrial cavity and 
(B) a huge soft tissue mass in the pelvis, complicated with (C) bilateral hydronephrosis. 
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Figure 2. Confirmation of the branching, filamentous Actinomyces bacterium. The bacterium was confirmed after staining with (A) 
Periodic acid-Schiff and (B) Gomori methenamine silver (GMS) and hematoxylin and eosin. The GMS stain shows the grey-black 
staining of actinomycosis. (C) The sulfur granules are composed of filamentous Actinomyces with a radial arrangement at the periph-
ery and surrounded by a rim of lymphocytes.
A B
Figure 3. Comparison of the abdominal computed tomography scans (A) on admission and (B) 2 years after diagnosis of actinomy-
cosis, showing almost complete resolution of the huge pelvic inflammatory mass.
this infection can be successfully treated with high-dose, 
long-term penicillin, even for a huge pelvic mass. An 
awareness of this disease will expedite diagnosis and treat-
ment and minimize unnecessary surgical interventions, 
morbidity, and mortality. 
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